TOSHA MCCANNON: Open Payments
NPI 1538670617 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,605 in 155 payments from 18 companies in 2025. Trend: 2023 $2,670 · 2024 $1,986 · 2025 $3,605
Food & beverage: $3,605
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 32 | $937 |
| AstraZeneca Pharmaceuticals LP | 18 | $608 |
| Regeneron Healthcare Solutions, Inc. | 12 | $274 |
| Pharming Healthcare, Inc. | 10 | $247 |
| GlaxoSmithKline, LLC. | 14 | $245 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $229 |
| Amgen Inc. | 14 | $179 |
| CSL Behring | 11 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $148 |
| Novartis Pharmaceuticals Corporation | 6 | $135 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, RUCONEST, NEFFY, NUCALA, NEMLUVIO, ORLADEYO.
Industry payments across GA — which companies pay providers there.
